Skip to content
Menu

Veracyte, Inc. VCYT

Full chart Compare
Set alert

Price alert · VCYT

All alert types
25.04 USD -0.53 (-2.07%)

Regular-session close

25.07 +0.03 +0.12%

After hours · Nov 19, 5:21 PM ET

24.95 Day range 26.63
21.91 52-week range 60.91
YTD
-40.52%
1 year
-37.29%

5D +1.60 (+6.53%)

242526FriMonTueWedThu26.11
Market cap
2.02B
Revenue (ttm)
581.78M
Profit margin
21.80%
EPS (ttm)
1.54
Shares out
80.70M
P/E ratio
16.26
Forward P/E
16.10
YTD return
-40.52%
1-year return
-37.29%
50-day average
41.06
Volume
1.87M
Avg volume
1.85M
Open
25.68
Previous close
25.57
Day's range
24.95 – 26.63
52-week range
21.91 – 60.91
Beta
1.96
Analysts
Buy
Price target
41.60 (+66.1%)
Earnings date
Feb 24, 2027

Key statistics

200-day average
42.18
Enterprise value
1.73B
Price / sales
3.47
Price / book
1.41
Revenue growth
15.10%
Free cash flow
110.92M
Total cash
370.53M
Total debt
40.74M
Return on equity
9.43%
Short % of float
13.99%

Fundamental scorecard

17 of 25 checks passed on VCYT’s reported financials

ValueGrowthProfitabilityHealthDividend

17of 25 checks passed

  • Value 4 of 5
  • Growth 5 of 5
  • Profitability 3 of 5
  • Financial health 5 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
VCYT Revenue — quarterly 151.75M
VCYT Net income — quarterly 31.50M
VCYT EPS — quarterly 0.39

Earnings

VCYT recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 24, 2027Dec 30, 20260.40———
Nov 4, 2026Sep 30, 20260.41020.51+0.10+24.33%
Jul 30, 2026Jun 30, 20260.41030.54+0.13+31.61%
May 5, 2026Mar 31, 20260.340.52+0.18+52.94%
Feb 25, 2026Dec 31, 20250.40830.53+0.12+29.81%
Nov 4, 2025Sep 30, 20250.320.51+0.19+59.38%

Upgrades / downgrades

VCYT analyst upgrades and downgrades
DateFirmActionFromTo
Nov 11, 2026Stephens & Co.mainOverweightOverweight
Nov 10, 2026Piper SandlermainOverweightOverweight
Nov 10, 2026Freedom Capital MarketsmainBuyBuy
Nov 9, 2026UBSmainBuyBuy
Nov 5, 2026Leerink PartnersdownOutperformMarket Perform
Nov 5, 2026NeedhammainBuyBuy

About Veracyte, Inc.

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.

Sector
Healthcare
Industry
Diagnostics & Research
Country
United States
Website
veracyte.com

News

Your note

Sign in to keep a note on VCYT — it syncs with the Stock Master app.

Insider holders

VCYT insider holders
InsiderRelationLatest transactionDateShares held
BARR ELIAVDirectorStock Award(Grant)Jun 10, 202656,461
BHANJI MUNADirectorSaleOct 18, 202640,854
CHAMBERS REBECCAChief Financial OfficerSaleSep 3, 2026166,025
EPSTEIN ROBERT SDirectorStock Award(Grant)Jun 10, 202657,718
FEBBO PHILLIP GOfficerSaleSep 3, 2026133,048
HAAS KEVIN RICHARDOfficerStock Award(Grant)Apr 9, 202644,221

Institution ownership

VCYT institution ownership
Holder% heldSharesValueReported
Blackrock Inc.17.21%13,887,188347.74MSep 29, 2026
FMR, LLC8.07%6,512,651163.08MSep 29, 2026
State Street Corporation6.86%5,532,737138.54MSep 29, 2026
Vanguard Portfolio Management LLC5.99%4,836,979121.12MSep 29, 2026
Vanguard Capital Management LLC4.46%3,600,33690.15MSep 29, 2026
ARK Investment Management, LLC3.67%2,964,65074.23MSep 29, 2026

Fund ownership

VCYT fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF5.93%4,787,107119.87MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.14%2,532,11063.40MJun 29, 2026
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF2.89%2,332,08158.40MSep 29, 2026
iShares Trust-iShares Russell 2000 ETF2.59%2,092,96852.41MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.27%1,830,64245.84MJun 29, 2026
ARK ETF Trust-ARK Genomic Revolution ETF1.99%1,609,81140.31MOct 30, 2026